Long-term follow-up of the CESS 81 and CESS 86 Ewing sarcoma trials. Eliciting early-response signals from first-in-human clinical trials and validation of prognostic scores in aggressive biology bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results